TLDR
- Northland upgraded ALAB to Outperform (Buy) with a $350 price target, implying ~9% upside from current levels.
- Analyst Gus Richard expects stronger earnings revisions and an extended AI infrastructure spending cycle pushing into 2027.
- A $200 billion Anthropic funding round and Nvidia’s $500 billion private capital announcement are seen as key catalysts.
- Astera Labs posted Q2 revenue of $392.4 million, up 104% year-over-year, beating EPS estimates by 15.9%.
- Q3 guidance of $540-$560 million is ahead of Wall Street’s prior consensus of $543.35 million.
Astera Labs is trading at $321.61 after Northland Securities upgraded the stock to Outperform from Market Perform, setting a price target of $350. That implies around 9% upside from where the stock sits today.
Astera Labs, Inc. Common Stock, ALAB
The upgrade comes from five-star analyst Gus Richard, who ranks 265 out of more than 12,479 analysts tracked by TipRanks. His track record on ALAB is clean, with a 100% success rate and an average return of 95.67% per rating over a one-year timeframe.
Richard’s core thesis is straightforward: Astera’s chip content per rack will keep rising, and the company is well-placed in two critical areas of AI infrastructure, switching fabric and signal conditioning.
He also called ALAB one of the fastest-growing chip suppliers in the AI infrastructure market, which is a strong statement in a crowded field.
Fresh Capital Extends the AI Spending Runway
The upgrade is backed by a wave of new private capital hitting the AI infrastructure space. Google, Broadcom, Blackstone, Morgan Stanley, and crypto miners recently committed $200 billion in funding for Anthropic.
On top of that, Nvidia and several major investment firms announced roughly $500 billion in new private capital last week. Richard believes this flow of money pushes the AI infrastructure spending peak into 2027.
That extended timeline is good news for Astera, which makes connectivity chips that sit at the heart of AI data center buildouts.
Q2 Beat and a Big Q3 Guide
Astera Labs delivered a strong Q2 earlier this month. Revenue came in at $392.4 million, up 104% year-over-year. Adjusted EPS hit $0.80, beating the $0.69 consensus by nearly 16%.
PCIe Gen 6 products drove the beat, making up over half of company revenue in Q2, up from about one-third in Q1. That’s a fast ramp by any measure.
The Scorpio X-Series AI fabric switches also moved into volume production ahead of schedule. Management said the product is on track to become Astera’s biggest product family by Q3.
For Q3, guidance came in at $540-$560 million in revenue and $1.16-$1.21 in adjusted EPS. Wall Street had been sitting at $543.35 million and $1.17 respectively, so the guide is largely in line to slightly ahead.
That kind of forward visibility, backed by strong order books, is what keeps analysts constructive on the name.
Wall Street holds a Moderate Buy consensus on ALAB, with 12 Buys and five Holds.
The average price target across analysts sits at $410.25, implying roughly 26.5% upside from current levels. Northland’s $350 target is on the lower end of that range, though 20 analysts have revised earnings estimates upward for the upcoming period.
InvestingPro’s Fair Value model does flag the stock as potentially overvalued at current prices, a point worth watching.
Stop guessing and start investing with confidence. KnockoutStocks gives you the AI insights, market intelligence, and stock research you need to spot opportunities, cut through the noise, and make smarter investment decisions — all in one powerful platform.
Sign up today and get 50% OFF full access to our premium stock picks.
Simply use coupon code SPECIAL50 at checkout to claim your exclusive discount.
